alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 276 Introduced in House (IH)]

103d CONGRESS
  1st Session
                                H. R. 276

To amend the Federal Election Campaign Act of 1971 to ban activities of 
  political action committees in elections for Federal office and to 
 reduce the limitation on contributions to candidates by persons other 
               than multicandidate political committees.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 5, 1993

  Mr. Mazzoli (for himself and Mr. Poshard) introduced the following 
   bill; which was referred to the Committee on House Administration

_______________________________________________________________________

                                 A BILL

 
To amend the Federal Election Campaign Act of 1971 to ban activities of 
  political action committees in elections for Federal office and to 
 reduce the limitation on contributions to candidates by persons other 
               than multicandidate political committees.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. BAN ON ACTIVITIES OF POLITICAL ACTION COMMITTEES IN 
              ELECTIONS FOR FEDERAL OFFICE.

    (a) In General.--Title III of the Federal Election Campaign Act of 
1971 (2 U.S.C. 431 et seq.) is amended by adding at the end the 
following new section:

  ``ban on federal election activities by political action committees

    ``Sec. 324. (a) Notwithstanding any other provision of this Act, no 
person other than an individual or a political committee may make 
contributions, solicit or receive contributions, or make expenditures 
for the purpose of influencing an election for Federal office.''.

SEC. 2. REDUCTION IN LIMITATION ON CONTRIBUTIONS TO CANDIDATES BY 
              PERSONS OTHER THAN MULTICANDIDATE POLITICAL COMMITTEES.

    Section 315(a)(1)(A) of the Federal Election Campaign Act of 1971 
(2 U.S.C. 441a(a)(1)(A)) is amended by striking out ``$1,000'' and 
inserting in lieu thereof ``$500''.

                                 <all>
```
----

**SECURITIES      AND EXCHANGE COMMISSION**

**FORM      8-K**

*Date      of report (Date of earliest event reported)*

**Petroleum      Development Corporation**

*Exact      Name of Registrant as Specified in Charter*

| **Nevada**                                                                    | **0-7246**                               | **95-2636730**                                                      |
|-------------------------------------------------------------------------------|------------------------------------------|---------------------------------------------------------------------|
| *State                or Other Jurisdiction**of                Incorporation* | *Commission**File                Number* | *IRS                Employer**Identification                Number* |

**120      Genesis Boulevard, Bridgeport, WV  26330**

*Address      of Principal Executive Offices*

**304-842-3597**

*Registrant's      telephone number, including area code*

| [                    ]    | Written                communications pursuant to Rule 425 under Securities Act (17 CFR                230.425)                                     |
|---------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                    |
| [                    ]    | Soliciting                material pursuant to Rule 14a-12 under the Exchange Act (17 CFR                240.14a-12)                                |
|                                                    |
| [                    ]    | Pre-commencement                communications pursuant to Rule 14d-2(b) under the Exchange Act (17                CFR                240.14d-2(b)) |
|                                                    |
| [                    ]    | Pre-commencement                communications pursuant to Rule 13e-4(c) under the Exchange Act (17                CFR                240.13e-4(c)) |

**No      Change**

*Former      Name or Former Address, if Changed Since Last Report*

| **Item                7.01** | **Regulation                FD Disclosure.** |
|------------------------------|----------------------------------------------|

**EXHIBIT      INDEX**

**Item      9.01.  Financial Statements and Exhibits.**

**News      Release:  **

**PowerPoint      Text:**
** **

**PETROLEUM      DEVELOPMENT CORPORATION**

| Date:  |  October                1, 2007         |
|--------|----------------------------------------------|
|   |                                         |
| By:    | /s/                Richard W. McCullough     |
|   |  Richard                W. McCullough   |
|   |  Chief                Financial Officer |
1 The Honorable Henry E. Autrey, United States District Judge for the Eastern District of Missouri. 

## United States Court of Appeals FOR THE EIGHTH CIRCUIT

___________ No. 05-2372

___________ Susan Carol Bishop, * * Appellant, * * v. * Appeal from the United States * District Court for the Western Surety Company; Jennifer * Eastern District of Missouri. Clark Williams; George Meyers; Greg * Melton, * [UNPUBLISHED] * Appellees. *

___________ Submitted: May 2, 2006 Filed: May 5, 2006

___________ Before RILEY, MAGILL, and GRUENDER, Circuit Judges.

___________ PER CURIAM. Susan Bishop (B ishop) appeals the district court’s 1 Federal Rule of Civil Procedure 12(b)(6) dismissal of her ci vil complaint. Having conducted de novo review of the dismissal, a nd having accepted the facts in the complaint as true and construing them in Bishop’s favor, seeSpringdale Educ. Ass’n v. Springdale Sch. Dist. , 133 F.3d 649, 651 (8th Cir. 1998), we find the district court’s analysis to be-2- thorough and well-reasoned, and we rej ect Bishop’s arguments for reversal. Accordingly, we affirm. See 8th Cir. R. 47B.

______________________________
EXHIBIT 32.1 
 STATEMENT
        REQUIRED BY 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
 TO
        SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  In
        connection with the Quarterly Report on Form 10-Q of China International
        Tourism
        Holdings Ltd. (the "Company") for the three months ended March 31, 2008,
        as
        filed with the Securities and Exchange Commission (the "Report"), I, Ming
        Lei,
        Chief Executive Officer of the Company, certify that:
  *
        the
        Report fully complies with the requirements of Section 13(a) or 15(d), as
        applicable, of the Securities Exchange Act of 1934; and
  *
        the
        information contained in the Report fairly presents, in all material respects,
        the financial condition and results of operations of the Company.
  /s/
        Ming
        Lei
 Ming
        Lei
  Chief
        Executive Officer
 
 
 Date:
        May
        14, 2008
 
 This
        certification accompanies this Report pursuant to Section 906 of the
        Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by
        the
        Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
        Section 18 of the Securities Exchange Act of 1934, as amended.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONSOLIDATED FINANCIAL STATEMENTS INCLUDED IN FORM 10-K AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         789,000
<SECURITIES>                                         0
<RECEIVABLES>                                3,556,000
<ALLOWANCES>                                  (15,000)
<INVENTORY>                                  3,729,000
<CURRENT-ASSETS>                             8,142,000
<PP&E>                                       5,918,000
<DEPRECIATION>                               4,446,000
<TOTAL-ASSETS>                              10,732,000
<CURRENT-LIABILITIES>                        4,834,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                  4,948,000
<COMMON>                                    19,993,000
<OTHER-SE>                                (21,053,000)
<TOTAL-LIABILITY-AND-EQUITY>                10,732,000
<SALES>                                     17,002,000
<TOTAL-REVENUES>                            17,002,000
<CGS>                                        8,409,000
<TOTAL-COSTS>                               10,824,000
<OTHER-EXPENSES>                           (2,010,000)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                            (82,000)
<INCOME-PRETAX>                            (4,159,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (4,159,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (4,159,000)
<EPS-BASIC>                                    (.47)
<EPS-DILUTED>                                    (.47)


</TABLE>
Exhibit 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER 

I certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. the Quarterly Report on Form 10-Q of LabOne, Inc. for the period ending March 31, 2005 (the "Report") fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of LabOne, Inc.

 

LabOne, Inc.

Date:  May 9, 2005
By  /s/ *John W. McCarty*
```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2694 Introduced in House (IH)]

103d CONGRESS
  1st Session
                                H. R. 2694

To amend the Federal Food, Drug, and Cosmetic Act and the Public Health 
    Service Act to require special testing for drugs and biological 
                        products used by women.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 21, 1993

  Mrs. Schroeder (for herself and Ms. Snowe) introduced the following 
    bill; which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
To amend the Federal Food, Drug, and Cosmetic Act and the Public Health 
    Service Act to require special testing for drugs and biological 
                        products used by women.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Pharmaceutical Interactions Safety 
Act''.

SEC. 2. CLINICAL INVESTIGATIONS.

    Section 505(b) of the Federal Food, Drug, and Cosmetic Act is 
amended by adding at the end the following:
    ``(4) Clinical investigations to be submitted as part of an 
application in accordance with paragraph (1)(A) shall include 
investigations of the possible interaction of the drug with relevant 
female or male hormones or related substances unless there is 
substantial evidence that there are no significant interactions between 
the drug under investigation and such substances or the inclusion of 
such investigations is otherwise inappropriate under guidelines 
established by the Secretary by rule.''.

SEC. 3. BIOLOGICAL PRODUCTS CLINICAL INVESTIGATIONS.  

    Section 351(c) of the Public Health Service Act (42 U.S.C. 262(c)) 
is amended by adding at the end the following:
    ``(3) Clinical investigations submitted as part of an application 
for a biological product in accordance with paragraph (1) shall include 
investigations of the possible interaction of the biological product 
with relevant female or male hormones or related substances unless 
there is substantial evidence that there are no significant 
interactions between the biological product under investigation and 
such substances or the inclusion of such investigations is otherwise 
inappropriate under guidelines established by the Secretary by rule.''.

                                 <all>
```
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Oregon Steel Mills, Inc. on Form 10-Q for the quarter ended March 31, 2006, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, James E Declusin, President and CEO of Oregon Steel Mills, Inc., and I, L. Ray Adams, Vice President of Finance and CFO of Oregon Steel Mills, Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

|(1) | The Report fully complies with the requirements of   section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m   or 78c(d)); and                 
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                                     
|(2) | The information contained in the Report fairly   presents, in all material respects, the financial condition and results of   operations of Oregon Steel Mills, Inc.

|/s/ James E. Declusin | 
|--------------------- | 
|                      | 
|James E. Declusin     | 
|President and CEO     | 
|                      | 
|May 1, 2006           | 

|/s/ L. Ray Adams             | 
|---------------------------- | 
|                             | 
|L. Ray Adams                 | 
|Vice President  Finance and | 
|Chief Financial Officer      | 
|                             | 
|May 1, 2006                  |
#### Clinton HILL, Petitioner-Appellant, v. Gene M. JOHNSON, Respondent-Appellee.

No. 09-7884.

United States Court of Appeals, Fourth Circuit.

Submitted Jan. 19, 2010.

Decided Jan. 28, 2010.

Clinton Hill, Appellant Pro Se. Benjamin Hyman Katz, Assistant Attorney General, Richmond, Virginia, for Appellee.

Before NIEMEYER, KING, and DAVIS, Circuit Judges.

Dismissed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Clinton Hill seeks to appeal the district court’s order accepting the recommendation of the magistrate judge and denying relief on his 28 U.S.C. § 2254 (2006) petition. The order is not appealable unless a circuit justice or judge issues a certificate of appealability. 28 U.S.C. § 2253(c)(1) (2006). A certificate of appealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2006). A prisoner satisfies this standard by demonstrating that reasonable jurists would find that any assessment of the constitutional claims by the district court is debatable or wrong and that any dispositive procedural ruling by the district court is likewise debatable. *Miller-El v. Cockrell,*537 U.S. 322, 336-38, 123 S.Ct. 1029, 154 L.Ed.2d 931 (2003); *Slack v. McDaniel,*529 U.S. 473, 484, 120 S.Ct. 1595, 146 L.Ed.2d 542 (2000); *Rose v. Lee,*252 F.3d 676, 683-84 (4th Cir.2001). We have independently reviewed the record and conclude that Hill has not made the requisite showing. Accordingly, we deny a certificate of appealability and dismiss the appeal. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*DISMISSED*
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 15-7509

PATRICK PARKER, a/k/a Mustafa Muhjahid,

Plaintiff - Appellant,

v.

DR. PETER OBER, Physician; DR. KING, Physician; LEONARD 

LEVIN; MICHELLE ROSSMAN, MD,

Defendants - Appellees.

Appeal from the United States District Court for the Eastern 

District of Virginia, at Norfolk. Mark S. Davis, District 

Judge. (2:13-cv-00490-MSD-DEM)

Submitted: March 25, 2016 Decided: May 17, 2016 

Before SHEDD, KEENAN, and HARRIS, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Patrick Parker, Appellant Pro Se. Jeff W. Rosen, PENDER & 

COWARD, PC, Virginia Beach, Virginia; Elizabeth Martin 

Muldowney, RAWLS, MCNELIS & MITCHELL, PC, Richmond, Virginia; 

John E. Peterson, Jr., HANCOCK DANIEL JOHNSON & NAGLE, PC, Glen 

Allen, Virginia, for Appellees.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Patrick Parker appeals the district court’s order granting 

Defendants’ motions for summary judgment or to dismiss for 

failure to state a claim Parker’s 42 U.S.C. § 1983 (2012) action 

alleging deliberate indifference to his medical needs. We have 

reviewed the record and find no reversible error. Accordingly, 

although we grant leave to proceed in forma pauperis, we affirm 

substantially for the reasons stated by the district court. 

Parker v. Ober, No. 2:13-cv-00490-MSD-DEM (E.D. Va. filed Aug. 

25, 2015 & entered Aug. 26, 2015). We dispense with oral 

argument because the facts and legal contentions are adequately 

presented in the materials before this court and argument would 

not aid the decisional process.

AFFIRMED
EXHIBIT 23.1


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We consent to the incorporation by reference in the Registration Statements (Nos. 333-42434, 333-119564, 333-147683, 333-166523 and 333-187142) on Form S-8; Registration Statements (Nos. 333-97746, 333-212787 and 333-213213) on Form F-3; and Registration Statement (No. 333-192753) on Form F-3ASR of Teekay Corporation (the "Company") of:





|  |                                                                                                                                                                                                                                                                                                                                                                                                                           
|- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|• | our reports dated April 12, 2017, with respect to the consolidated balance sheets of the Company as of December 31, 2016 and 2015, and the related consolidated statements of income, comprehensive income, cash flows and changes in total equity for each of the years in the three-year period ended December 31, 2016, and the effectiveness of internal control over financial reporting as of December 31, 2016; and

|  |                                                                                                                                                                                                                                                                        
|- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|• | our report dated April 21, 2015, with respect to the consolidated statement of financial position of Exmar LPG BVBA as at December 31, 2014 and the consolidated statements of income, comprehensive income, equity and cash flows for the year ended December 31, 2014

which reports appear in the December 31, 2016 Annual Report on Form 20-F of Teekay Corporation.





/s/ KPMG LLP


Chartered Professional Accountants


Vancouver, Canada


April 12, 2017
Form 8908

(Rev. February 2020)

Department of the Treasury 

Internal Revenue Service 

Energy Efficient Home Credit

▶ Attach to your tax return.

▶ Go to www.irs.gov/Form8908 for instructions and the latest information.

OMB No. 1545-1979

Attachment 

Sequence No. 153

Name(s) shown on return Identifying number 

1a Enter the total number of qualified energy efficient homes including qualified 

energy efficient manufactured homes meeting the 50% standard that were 

sold or leased to another person for use as a residence during the tax year 

(see instructions) . . . . . . . . . . . . . . . . . . . . 1a 

b Multiply line 1a by $2,000. . . . . . . . . . . . . . . . . . . . . . . . . . 1b 

2a Enter the total number of qualified energy efficient manufactured homes

meeting the 30% standard that were sold or leased to another person for use

as a residence during the tax year (see instructions) . . . . . . . . . 2a 

b Multiply line 2a by $1,000. . . . . . . . . . . . . . . . . . . . . . . . . . 2b 

3 Energy efficient home credit from partnerships and S corporations (see instructions) . . . . . . 3 

4 Add lines 1b, 2b, and 3. Partnerships and S corporations, report this amount on Schedule K. All 

others, report this amount on Form 3800, Part III, line 1p . . . . . . . . . . . . . . . 4 

For Paperwork Reduction Act Notice, see separate instructions. Cat. No. 37718T Form 8908 (Rev. 2-2020)
[No. 35653-8-II.

Division Two.

August 28, 2007.]

#### Barbara Sayers, *Appellant,*v. Wesley N. Sayers et al., *Respondents.*

Appeal from a judgment of the Superior Court for Kitsap County, No. 05-2-00782-8, Leonard W. Costello, J., entered October 17, 2006. *Affirmed*by unpublished opinion per Van Deren, A.C.J., concurred in by Armstrong and Penoyar, JJ.